Column: 'It feels like a second-class shot.' Johnson & Johnson's vaccine equity problem

The COVID-19 vaccine from Johnson & Johnson will save lives. But public health officials must address the false narrative that it’s a lesser vaccine.

Source: Los Angeles Times